TG Therapeutics Inc (TGTX)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 20,633 | -192,839 | -344,770 | -273,594 | -169,055 |
| Total assets | US$ in thousands | 329,587 | 193,572 | 379,629 | 625,642 | 163,014 |
| Operating ROA | 6.26% | -99.62% | -90.82% | -43.73% | -103.71% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $20,633K ÷ $329,587K
= 6.26%
TG Therapeutics Inc's operating return on assets (Operating ROA) has varied significantly over the past five years, indicating fluctuations in the company's operating efficiency and asset utilization. In 2023, the operating ROA improved significantly to 6.26% from previous years. This positive improvement suggests that the company was able to generate more operating income relative to its assets in the most recent year.
The negative values observed in 2022, 2021, 2020, and 2019 indicate that in those years, the company's operating income was insufficient to cover the costs associated with its assets. Particularly in 2022, the Operating ROA was drastically low at -99.62%, indicating significant operational inefficiencies or challenges that year.
Overall, the significant fluctuations in TG Therapeutics Inc's Operating ROA over the years suggest that the company's operational performance and asset utilization have been inconsistent. Further analysis of the underlying factors driving these fluctuations would be necessary to better understand the company's operational efficiency and financial performance.
Peer comparison
Dec 31, 2023